Give Hope Blog
ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL
June 28, 2019 | City of Hope
At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.
Joanne Mortimer, M.D., named ASCO fellow, recognized for extraordinary service
March 27, 2019 | Samantha Bonar
Joanne Mortimer, M.D., was one of just 25 oncologists nationwide named a fellow of the American Society of Clinical Oncology for 2019. The distinction recognizes ASCO members for their extraordinary volunteer service, dedication and commitment to ASCO.
City of Hope doctor co-edits annual report highlighting cancer breakthroughs
January 31, 2019 | Michael Easterling
Sumanta K. Pal, M.D., was selected to serve as one of three editors of this year’s Clinical Cancer Advances, an annual report on the progress against cancer distributed by the American Society of Clinical Oncology.
Groundbreaking $2 million study will focus on family caregivers
October 15, 2018 | Maxine Nunes
City of Hope researchers have just received a $2 million grant from the National Cancer Institute to study a crucial but rarely examined aspect of patient care and quality of life — the family caregiver.
National Cancer Meeting Highlights the Expanding Role of Immunology
June 19, 2018 | Cary Presant, M.D.
At the annual 2018 meeting of the American Society of Clinical Oncology (ASCO) in Chicago, I was among the 40,000 oncologists impressed with how effective immunotherapy can be in some patients with cancer.
City of Hope Guides ASCO’s New Geriatric Cancer Recommendations
June 8, 2018 | Saundra Young
City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.
Load MoreBack To Top